Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
CD4+ and CD8+ T cells are not the main driver of Lassa fever pathogenesis in macaques
Jérémie Prévost, … , Kyle Rosenke, David Safronetz
Jérémie Prévost, … , Kyle Rosenke, David Safronetz
Published September 25, 2025
Citation Information: JCI Insight. 2025;10(22):e199235. https://doi.org/10.1172/jci.insight.199235.
View: Text | PDF
Research Article Microbiology Public Health Virology

CD4+ and CD8+ T cells are not the main driver of Lassa fever pathogenesis in macaques

  • Text
  • PDF
Abstract

Empirical data from survivors of Lassa fever and experimental disease modeling efforts, particularly those using mouse models, are at odds with respect to T cell–mediated pathogenesis. In mice, T cells have been shown to be imperative in disease progression and lethality, whereas in humans, an early and robust T cell response has been associated with survival. Here, we assessed the role of CD4+ and CD8+ T cells on disease progression and severity of Lassa virus infection in a nonhuman primate model. Using an antibody-mediated T cell depletion strategy prior to and after inoculation, we were able to examine Lassa virus infection in the absence of specific T cell responses. In animals depleted for either CD4+ or CD8+ T cells, Lassa virus infection remained uniformly lethal, with only a slight delay in disease progression was observed in the CD4-depleted group when compared with nondepleted controls. Milder pulmonary pathology was noticed in the absence of CD4+ or CD8+ T cells. Overall, our findings suggest that T cells have a limited effect on the development of Lassa fever in nonhuman primates.

Authors

Jérémie Prévost, Nikesh Tailor, Geoff Soule, Jonathan Audet, Yvon Deschambault, Robert Vendramelli, Jessica Prado-Smith, Kevin Tierney, Kimberly Azaransky, Darwyn Kobasa, Chad S. Clancy, Heinz Feldmann, Kyle Rosenke, David Safronetz

×

Figure 6

Host immune responses of T cell–depleted LASV-infected cynomolgus macaques.

Options: View larger image (or click on image) Download as PowerPoint
Host immune responses of T cell–depleted LASV-infected cynomolgus macaqu...
(A) Serum samples collected from LASV-infected NHPs at regular intervals before and after infection were monitored for the presence of 30 cytokines/chemokines using a multiplex fluorescent bead-based immunoassay. Cytokine scores (CytoScore) were calculated as the linear combination of all 30 analytes. (B–P) Percentages of circulating monocyte (B–D), CD4+ T cell (E–J), and CD8+ T cell (K–P) populations were monitored from fresh EDTA-treated whole blood during routine exams (–7, –4, –1, 4, 7, and 10 DPI) and terminal necropsy exams using flow cytometry. (B–D) The different monocyte populations were characterized by a differential expression of CD14 and CD16. (E–P) The different T cell populations were characterized by a differential expression of CD45RA and CCR7 (TN, TEFF, TMEM) and CD69 (activated) as well as CXCR3 and CCR4 (Th1/Tc1, Th2/Tc2). Tc, cytotoxic T cells; TEFF, effector T cells; TMEM, memory T cells; TN, naive T cells. (Q and R) Serum samples collected from LASV-infected NHPs at regular intervals after the infection were monitored IgM (Q) and IgG (R) antibody responses mediated against LASV nucleoprotein (N) and glycoproteins (GP) using a commercial ELISA assay. Dashed lines represent the limit of detection of the assay. (A–R) Data are represented as connecting lines for each individual animal.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts